CVS Stock Overview
Provides health solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$53.20 |
| 52 Week High | US$75.52 |
| 52 Week Low | US$48.83 |
| Beta | 0.54 |
| 11 Month Change | -0.62% |
| 3 Month Change | 0.57% |
| 1 Year Change | -14.69% |
| 33 Year Change | -36.38% |
| 5 Year Change | -23.31% |
| Change since IPO | 139.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.9% | 1.0% | -0.5% |
| 1Y | -14.7% | 19.2% | 8.3% |
Return vs Industry: CVS underperformed the German Healthcare industry which returned 19.2% over the past year.
Return vs Market: CVS underperformed the German Market which returned 8.3% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 5.9% |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: CVS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | €63.58b |
| Earnings (TTM) | €4.76b |
| Revenue (TTM) | €348.85b |
13.3x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$367.25b |
| Cost of Revenue | US$316.53b |
| Gross Profit | US$50.71b |
| Other Expenses | US$45.70b |
| Earnings | US$5.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.99 |
| Gross Margin | 13.81% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 85.4% |
How did CVS perform over the long term?
See historical performance and comparison